(Q42501473)

1 November 2017

title

Cytokeratin profiles of male breast cancers (English)

1 reference

1 November 2017

11

1 reference

1 November 2017

Ciocca V

1

1 reference

1 November 2017

Bombonati A

2

1 reference

1 November 2017

Gatalica Z

3

1 reference

1 November 2017

Di Pasquale M

4

1 reference

1 November 2017

Milos A

5

1 reference

1 November 2017

Ruiz-Orrico A

6

1 reference

1 November 2017

Dreher D

7

1 reference

1 November 2017

Folch N

8

1 reference

1 November 2017

Monzon F

9

1 reference

1 November 2017

Santeusanio G

10

1 reference

1 November 2017

Bernard PS

12

1 reference

1 November 2017

Palazzo JP

13

1 reference

1 November 2017

publication date

1 October 2006

1 reference

1 November 2017

1 reference

1 November 2017

volume

49

1 reference

1 November 2017

issue

4

1 reference

1 November 2017

page(s)

365-370

1 reference

1 November 2017

cites work

Breast cancer in men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Carcinoma of the breast in males: a multiinstitutional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Is male breast cancer similar or different than female breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

The distinctive nature of HER2-positive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Expression of luminal and basal cytokeratins in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

Her-2/neu gene amplification and protein expression in primary male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02519.X

10.1111/J.1365-2559.2006.02519.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference